Drug intelligence / Profile preview

Tetrahydrofolic acid

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Intravenous, Intramuscular
01

Overview

Tetrahydrofolic acid (also known as tetrahydrofolate or THFA) is a biologically active derivative of folic acid and serves as the main active metabolite of dietary folate. It is produced from dihydrofolic acid by the enzyme dihydrofolate reductase and can be further converted into 5,10-methylenetetrahydrofolate by serine hydroxymethyltransferase. Tetrahydrofolic acid functions as a coenzyme in numerous metabolic reactions, particularly those involved in the synthesis of amino acids and nucleic acids. It acts as a carrier for single-carbon groups (such as methyl, methylene, formyl), which are essential for DNA synthesis and other biosynthetic processes. Deficiency in tetrahydrofolic acid can lead to impaired cell division and megaloblastic anemia. Clinically, it is used for nutritional supplementation to treat or prevent folate deficiency states such as megaloblastic anemia and during pregnancy to prevent neural tube defects[1][2][3][5][8].

Other names
TetrahydrofolateTHFA
02

Targets

DHFR (Dihydrofolate reductase)SHMT2 (Serine hydroxymethyltransferase 2)THF-II riboswitch

Beyond the preview

Go deeper on Tetrahydrofolic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tetrahydrofolic acid.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call